Physician profile
Alan R Erickson
NPI 1538119169
$1,400.00
in general payments reported to CMS, 2019-2025
16 companies · $89.94 in 2025
The $89.94 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $403 · 2020: $113 · 2021: $151 · 2022: $434 · 2023: $113 · 2024: $96.32 · 2025: $89.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $299.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $260.67 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $148.68 | 2019-2024 | |
| Allergan, INC. | $146.68 | 2019-2022 | |
| Oyster Point Pharma, INC. | $142.37 | 2022-2024 | Tyrvaya, Ryzumvi |
| Heru, INC. | $141.51 | 2022 | |
| Bausch & Lomb Americas INC. | $129.05 | 2022-2025 | Vyzulta |
| Abbvie INC. | $114.45 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $80.09 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $53.76 | 2019-2021 | |
| Alcon Vision LLC | $43.58 | 2019-2023 | Total30 |
| Thea Pharma INC. | $38.89 | 2023-2025 | Iyuzeh |
| Tarsus Pharmaceuticals, INC. | $37.14 | 2025 | Xdemvy |
| Rxsight INC | $22.60 | 2022 | |
| Ocular Therapeutix, INC. | $14.42 | 2019 | |
| Omeros Corporation | $13.16 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $12.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Erickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.